Cart
sales@molnova.com
Vancomycin
CAS No. 1404-90-6
Vancomycin ( —— )
Catalog No. M11695 CAS No. 1404-90-6
An antibiotic used to treat a number of bacterial infections that acts by inhibiting proper cell wall synthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 45 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVancomycin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn antibiotic used to treat a number of bacterial infections that acts by inhibiting proper cell wall synthesis.
-
DescriptionAn antibiotic used to treat a number of bacterial infections that acts by inhibiting proper cell wall synthesis.Bacterial Infection Approved
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
IndicationBacterial Infection
Chemical Information
-
CAS Number1404-90-6
-
Formula Weight1449.25
-
Molecular FormulaC66H75Cl2N9O24
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
-
Chemical NameVancomycin
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Cefditoren pivoxil
A third-generation cephalosporin antibiotic that has been used to treat bacterial infections of the skin and respiratory tract.
-
Sinapaldehyde
Sinapaldehyde is a natural product. Sinapaldehyde exhibits moderate antibacterial against Methicillin resistant S. aureus (MRSA) and E. coli with MIC values of 128 and 128 μg/mL.
-
Ceforanide
Ceforanide is a second-generation cephalosporin antibiotic with bactericidal activity. Ceforanide causes inhibition of bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall.
